Basic Information
Remepy is a pioneer in hybrid medicine: combining traditional drugs with digital therapeutics to enable personalization and enhance treatment efficacy. Remepy has demonstrated the effectiveness of its products in human studies, utilizing extensive brain imaging as well as blood and saliva samples, achieving promising results in oncology, MCI, and Parkinson's disease. Their approach provides an effective method for creating new proprietary pharmaceutical assets, thereby opening up an entirely new market and data landscape.